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Opening Editorial
Public health in practice in a time of change
Heraclitus, the Greek philosopher, once said that the only constant in
life is change.
The past century has seen many momentous events and change: ep-
idemics of inﬂuenza, HIV/AIDS and Ebola; World Wars and global con-
ﬂict; mass industrialisation and globalisation; development of the social
welfare state, health insurance and national health systems; the emer-
gence of transnational industries; and the Age of the Internet. Numerous
ground-breaking advances in medicine have had a signiﬁcant impact on
public health - advances in medical therapeutics mean many more
medical conditions are treatable today compared to a century ago. The
development of contraception alongside the emancipation of women
have improved the life chances and health of women globally. And we
are living longer and have healthier lives compared to our forebears.
The discovery of antibiotics has meant many once fatal infectious
diseases are now curable. In the early years this fed an optimistic belief
that the scourge of infectious diseases could be eliminated. However, the
rise of antibiotic resistance in recent years has led to fears of the end of
the antibiotic era [1,2]. Our microbial enemies have evolved and
continue to pose an increasing threat. Similarly, there were early hopes
that the development of vaccines could lead to the eradication of
vaccine-preventable diseases. Thus far only smallpox has been eliminated
whilst the eradication of other diseases has proven extremely chal-
lenging. Many developed countries, with well-established childhood
vaccination programmes, have seen in recent decades a rise in
anti-vaccination sentiment [3], driven in part by the emergence of social
media - a new technology that did not exist a century before.
Technological advances have also created new threats – industrial
pollutants, vehicular emissions, pesticides, microplastics, vaping, frack-
ing to name a few. Many of these new threats have local as well as global
effects. We have seen the impact of chloroﬂuorocarbons on the ozone
layer and anthropogenic global warming caused by our carbon-based
economies worldwide. Widespread global degradation of the environ-
ment and natural resources, coupled with exponential global population
growth, has sparked concerns that we are living beyond what the planet
can sustain. There is now growing cognizance of the idea of “planetary
health” that encapsulates the intricate and complex links between the
fate of the planet and humankind as we know it [4].
However, as the French novelist Jean-Baptiste Karr has been oft
quoted, plus ça change, plus c’est la me^me chose - the more things change,
the more they stay the same.
Climate change is a pressing concern now and is likely to remain a
major environmental and public health anxiety for the foreseeable future.
With the urbanisation of the global population, urban health issues will
rise in prominence. Many of the public health threats of old persist, such
as tuberculosis, malaria, dengue fever, measles and inﬂuenza. Chronic
diseases such as diabetes, cardiovascular diseases, emphysema and
multimorbidity will continue to account for much population ill health
especially when one considers the global obesity epidemic and aging
populations worldwide. And nowhere is immune to natural disasters and
their consequences.
There has also been greater awareness of the power of the wider
determinants of health, from social conditions, cultural norms, macro-
economic conditions, to government policy. ‘Twas ever thus – this was
true of 1st Century Rome, 19th Century Britain, or indeed any country in
the future. The distribution of wealth both within and between countries
has considerable effects on public health outcomes [5]. The inﬂuence of
other dominant actors such as the pharmaceutical industry, food and
alcohol industry, transnational tobacco companies, also exert signiﬁcant
inﬂuence on population health. The industrial scale of the sale and use of
tobacco products, for example, has led to the global epidemic of
tobacco-related ill health and deaths in the past century [6]. Public
health policy has always been and continues to be susceptible to the
vested interests of powerful actors.
What then is the role of public health practitioners, academics and
policymakers against this backdrop of global challenges? Public health is
a scientiﬁc discipline rooted in evidence that seeks to promote and pro-
tect the health of populations. Technological advances provide new op-
portunities to do this. Developments in artiﬁcial intelligence allow
“precision” public health where populations can be segmented and risk
stratiﬁed, and tailored interventions can be targeted at these subgroups.
Advances in genomics and genetic epidemiology have improved our
understanding of these key biological determinants of health and disease,
and research into gene editing and genetic manipulation offer potentially
new interventions. Vaccine science has improved to such an extent that
new vaccines can be developed in a fairly short time period, offering
more timely response to disease outbreaks.
However, technological advances are not immune from bioethical
concerns. The development of prenatal testing, for example, sparked
concerns around the ethics of this technology with opponents seeing it as
a form of eugenics [7]. High healthcare costs and resource constraints
mean the age old debate between utilitarian and deontological view-
points persist – do we intervene to maximise health beneﬁt for the
greatest number, or is our priority maximising health for those in-
dividuals with the greatest need? Health resource allocation dilemmas
will persist as we continue to seek the optimal health system that is
efﬁcacious, equitable, efﬁcient and affordable [8] – an illusory public
health Nirvana that may not exist.
Public health practice is also an art [9] – on how to inﬂuence policy,
develop strategy, implement interventions, and effect population
behaviour change. Public health is often a political issue due to the scale
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of national resources and change required. Practitioners have to keep
reﬁning public health messages and honing their interventions to ﬁt with
population (and political) needs, expectations and demands. Neither is
the application of public health evidence straightforward as context is
all-important and the evidence has to be tailored to local settings.
In recognition of how contexts and public health practice continues to
evolve, this new journal sets out address the need for more public health
evidence in practice. Public health happens in the real world, beyond the
ivory towers of academia. There is a role for ‘high’ evidence but we must
not ignore the value and power of evidence that emerges out of public
health practice, i.e. what happens in reality in vivo. There can be no
rationale justiﬁcation for ignoring insights from practice. We hope this
journal addresses this need, and that you our readers will enjoy its con-
tents. More importantly, we hope the insights published will help inform
and shape public health practice, and lead to real impacts that beneﬁt the
public’s health.
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